Riviciclib

• Description:

  A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  438.3

• Molecular Formula:

  C21H20ClNO5.HCl

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK1/CyclinB| CDK2/CyclinA| CDK4/CyclinD1| CDK6/CyclinD3| CDK9/CyclinT1

• CAS Number:

  920113-03-7